JOINT FILING AGREEMENTJoint Filing Agreement • March 2nd, 2005 • Novartis Ag • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D with respect to the beneficial ownership of shares of Common Stock of Eon Labs, Inc. is filed jointly, on behalf of each of them. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
by and amongAgreement and Plan of Merger • March 2nd, 2005 • Novartis Ag • Pharmaceutical preparations • Delaware
AGREEMENT FOR PURCHASE AND SALE OF STOCK OF EON LABS, INC. by and between NOVARTIS CORPORATION, as PURCHASER, SANTO HOLDING (DEUTSCHLAND) GMBH, as SELLER, AND, FOR THE PURPOSES OF SECTION 12 ONLY, NOVARTIS AG Dated as of February 20, 2005 TABLE OF...Agreement for Purchase and Sale • March 2nd, 2005 • Novartis Ag • Pharmaceutical preparations
February 11, 2005 Novartis Corporation 608 Fifth Avenue New York, NY 10020 CONFIDENTIALITY AGREEMENT Ladies and Gentlemen: In order to allow you to evaluate a possible negotiated (except as permitted by this letter agreement) transaction (the...Novartis Ag • March 2nd, 2005 • Pharmaceutical preparations • Delaware
In order to allow you to evaluate a possible negotiated (except as permitted by this letter agreement) transaction (the "PROPOSED TRANSACTION") with Eon Labs, Inc. (the "COMPANY"), you have requested, following your execution and delivery to us of this letter agreement, certain information about the properties, employees, finances, businesses and operations of the Company. All information about the Company and its subsidiaries, whether oral, written or electronic, furnished by us or our Representatives (as defined below), whether furnished before or after the date hereof, is referred to in this letter agreement as "EVALUATION MATERIAL". Evaluation Material also includes all notes, analyses, compilations, studies, interpretations or other documents prepared by or for you or your Representatives which contain, reflect or are based upon, in whole or in part, the information furnished to you or your Representatives pursuant hereto. Evaluation Material does not include, however, information
